WatchPAT In Detection Of Central Disordered Breathing Events

Overview

About this study

The purpose of this study is to compare the agreement of WatchPAT300 to the gold standard in-laboratory polysomnography (PSG) at detecting central events in adult patients referred to the sleep laboratory for suspected obstructive and/or central sleep apnea.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • ≥ 18 years old.
  • Suspected obstructive and/or central sleep apnea who are scheduled to undergo in-laboratory diagnostic or split-night PSG at the Center for Sleep Medicine at Mayo Clinic in Rochester. 
  • Willing and able to provide written informed consent.

Exclusion Criteria:

  • Chronic atrial fibrillation.
  • Permanent pacemaker, or finger deformity precluding WatchPAT300 finger probe use.
  • Patients will also be excluded if they are prescribed any of the following medications:
    • alpha antagonists; or
    • short-acting nitrates. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mithri Junna, M.D.

Contact us for the latest status

Contact information:

Mithri Junna

5072663648

junna.mithri@mayo.edu

More information

Publications

Publications are currently not available